STOCK TITAN

[Form 4] Verisk Analytics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Elizabeth Mann, Chief Financial Officer of Verisk Analytics (VRSK), reported a sale of common stock on 08/15/2025. The filing shows 300 shares were disposed of at a reported price of $268 per share, leaving Ms. Mann with 15,465 shares beneficially owned. The filing identifies the sale code "S" and notes the transaction was executed pursuant to a 10b5-1 trading plan established on December 13, 2024. The Form 4 was signed by an attorney-in-fact and filed on 08/18/2025. The document contains no derivative transactions or other amendments.

Elizabeth Mann, Chief Financial Officer di Verisk Analytics (VRSK), ha comunicato la vendita di azioni ordinarie il 15/08/2025. La pratica indica che sono state cedute 300 azioni a un prezzo riportato di $268 per azione, lasciando a Ms. Mann 15.465 azioni di proprietà effettiva. Il documento identifica il codice di vendita "S" e specifica che l'operazione è stata eseguita ai sensi di un piano di negoziazione 10b5-1 istituito il 13 dicembre 2024. Il Modulo 4 è stato firmato da un procuratore ed è stato presentato il 18/08/2025. Il documento non contiene transazioni su derivati né altre modifiche.

Elizabeth Mann, directora financiera de Verisk Analytics (VRSK), informó la venta de acciones ordinarias el 15/08/2025. La presentación muestra que se dispusieron 300 acciones a un precio informado de $268 por acción, dejando a la Sra. Mann con 15.465 acciones en propiedad beneficiaria. La presentación identifica el código de venta "S" y señala que la transacción se ejecutó conforme a un plan de negociación 10b5-1 establecido el 13 de diciembre de 2024. El Formulario 4 fue firmado por un apoderado y presentado el 18/08/2025. El documento no contiene transacciones con derivados ni otras enmiendas.

Verisk Analytics (VRSK)의 최고재무책임자(Chief Financial Officer) 엘리자베스 만(Elizabeth Mann)은 2025년 8월 15일 보통주 매도를 보고했습니다. 제출 서류에 따르면 300주가 주당 $268의 보고 가격으로 처분되어 만 씨는 15,465주의 실질 보유 주식을 유지하게 되었습니다. 서류는 매도 코드 "S"를 표시하고 해당 거래가 2024년 12월 13일에 설정된 10b5-1 거래 계획에 따라 실행되었음을 명시합니다. 양식 4는 대리인이 서명하여 2025년 8월 18일 제출되었습니다. 문서에는 파생상품 거래나 기타 수정 사항이 없습니다.

Elizabeth Mann, directrice financière (CFO) de Verisk Analytics (VRSK), a déclaré une vente d'actions ordinaires le 15/08/2025. Le dépôt indique que 300 actions ont été cédées au prix déclaré de 268 $ par action, laissant Mme Mann détentrice de 15 465 actions en propriété bénéficiaire. Le dossier identifie le code de vente "S" et précise que la transaction a été exécutée en vertu d'un plan de négociation 10b5-1 établi le 13 décembre 2024. Le formulaire 4 a été signé par un mandataire et déposé le 18/08/2025. Le document ne contient ni transactions sur dérivés ni autres amendements.

Elizabeth Mann, Chief Financial Officer von Verisk Analytics (VRSK), meldete am 15.08.2025 den Verkauf von Stammaktien. Die Einreichung zeigt, dass 300 Aktien zu einem berichteten Preis von $268 pro Aktie veräußert wurden, womit Frau Mann weiterhin 15.465 Aktien wirtschaftlich besitzt. Die Meldung nennt den Verkaufscode "S" und weist darauf hin, dass die Transaktion gemäß einem am 13. Dezember 2024 eingerichteten 10b5-1-Handelsplan ausgeführt wurde. Das Formular 4 wurde von einem Bevollmächtigten unterschrieben und am 18.08.2025 eingereicht. Das Dokument enthält keine Derivattransaktionen oder andere Änderungen.

Positive
  • Sale executed under a 10b5-1 trading plan, indicating a pre-established, rule-compliant transaction
  • Filing includes clear disclosure of price ($268) and post-transaction beneficial ownership (15,465 shares)
Negative
  • CFO disposed of 300 shares, reducing insider holdings by that amount
  • No additional context in the filing about the proportion of ownership relative to total outstanding shares

Insights

TL;DR Insider sale of 300 shares under a pre-established 10b5-1 plan; holding remains material at 15,465 shares.

The report documents a routine, planned disposition by the CFO executed under a 10b5-1 plan dated 12/13/2024. The transaction code "S" and the explanation confirm the sale was prearranged rather than ad hoc. The disclosed price per share is $268 and the remaining beneficial ownership is 15,465 shares. No options, warrants, or other derivative activity are reported, and the filing appears administrative and informational in nature.

TL;DR Filing reflects compliance with Section 16 reporting and use of an affirmative-defense trading plan.

The Form 4 clearly identifies the reporting person as an officer (CFO) and shows the transaction was carried out under a 10b5-1 plan, which supports compliance with insider trading rules. The signature by an attorney-in-fact and the inclusion of an explanatory note enhance transparency. There are no amendments or other reportable changes in ownership forms or derivative holdings in this filing.

Elizabeth Mann, Chief Financial Officer di Verisk Analytics (VRSK), ha comunicato la vendita di azioni ordinarie il 15/08/2025. La pratica indica che sono state cedute 300 azioni a un prezzo riportato di $268 per azione, lasciando a Ms. Mann 15.465 azioni di proprietà effettiva. Il documento identifica il codice di vendita "S" e specifica che l'operazione è stata eseguita ai sensi di un piano di negoziazione 10b5-1 istituito il 13 dicembre 2024. Il Modulo 4 è stato firmato da un procuratore ed è stato presentato il 18/08/2025. Il documento non contiene transazioni su derivati né altre modifiche.

Elizabeth Mann, directora financiera de Verisk Analytics (VRSK), informó la venta de acciones ordinarias el 15/08/2025. La presentación muestra que se dispusieron 300 acciones a un precio informado de $268 por acción, dejando a la Sra. Mann con 15.465 acciones en propiedad beneficiaria. La presentación identifica el código de venta "S" y señala que la transacción se ejecutó conforme a un plan de negociación 10b5-1 establecido el 13 de diciembre de 2024. El Formulario 4 fue firmado por un apoderado y presentado el 18/08/2025. El documento no contiene transacciones con derivados ni otras enmiendas.

Verisk Analytics (VRSK)의 최고재무책임자(Chief Financial Officer) 엘리자베스 만(Elizabeth Mann)은 2025년 8월 15일 보통주 매도를 보고했습니다. 제출 서류에 따르면 300주가 주당 $268의 보고 가격으로 처분되어 만 씨는 15,465주의 실질 보유 주식을 유지하게 되었습니다. 서류는 매도 코드 "S"를 표시하고 해당 거래가 2024년 12월 13일에 설정된 10b5-1 거래 계획에 따라 실행되었음을 명시합니다. 양식 4는 대리인이 서명하여 2025년 8월 18일 제출되었습니다. 문서에는 파생상품 거래나 기타 수정 사항이 없습니다.

Elizabeth Mann, directrice financière (CFO) de Verisk Analytics (VRSK), a déclaré une vente d'actions ordinaires le 15/08/2025. Le dépôt indique que 300 actions ont été cédées au prix déclaré de 268 $ par action, laissant Mme Mann détentrice de 15 465 actions en propriété bénéficiaire. Le dossier identifie le code de vente "S" et précise que la transaction a été exécutée en vertu d'un plan de négociation 10b5-1 établi le 13 décembre 2024. Le formulaire 4 a été signé par un mandataire et déposé le 18/08/2025. Le document ne contient ni transactions sur dérivés ni autres amendements.

Elizabeth Mann, Chief Financial Officer von Verisk Analytics (VRSK), meldete am 15.08.2025 den Verkauf von Stammaktien. Die Einreichung zeigt, dass 300 Aktien zu einem berichteten Preis von $268 pro Aktie veräußert wurden, womit Frau Mann weiterhin 15.465 Aktien wirtschaftlich besitzt. Die Meldung nennt den Verkaufscode "S" und weist darauf hin, dass die Transaktion gemäß einem am 13. Dezember 2024 eingerichteten 10b5-1-Handelsplan ausgeführt wurde. Das Formular 4 wurde von einem Bevollmächtigten unterschrieben und am 18.08.2025 eingereicht. Das Dokument enthält keine Derivattransaktionen oder andere Änderungen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mann Elizabeth

(Last) (First) (Middle)
C/O VERISK ANALYTICS, INC.
545 WASHINGTON BOULEVARD

(Street)
JERSEY CITY NJ 07310

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Verisk Analytics, Inc. [ VRSK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 S 300(1) D $268 15,465 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares were sold pursuant to a 10b5-1 plan that Ms. Mann entered into on December 13, 2024.
/s/ Kathy Card Beckles, Attorney-in-fact 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Verisk Analytics

NASDAQ:VRSK

VRSK Rankings

VRSK Latest News

VRSK Latest SEC Filings

VRSK Stock Data

37.42B
139.35M
0.25%
96.24%
1.69%
Consulting Services
Services-computer Processing & Data Preparation
Link
United States
JERSEY CITY